HIV/AIDS
New HIV/AIDS Research from Texas Tech University Described
Published in AIDS Weekly, September 5th, 2011
2011 SEP 5 -- "Inspired by the anti-human immunodeficiency virus (HIV) activity of analogues of beta-galactosylceramide (GalCer), a set of mono- and di-saccharide fatty acid esters were designed as GalCer mimetics and their binding to the V3 loop peptide of HIV-1 and anti-HIV activity evaluated. 1,1-linked Gal-Man and Glu-Man disaccharides with an ester on the Man subunit bound the V3 loop peptide and inhibited HIV infectivity in single round infection assays with the TZM-bl cell line," researchers in El Paso, Texas report.
"IC50's were in the 50 mc M range with no toxicity to the cells at concentrations up to 200 mc M. These compounds appear to inhibit...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2011-09-05)
More Articles from AIDS Weekly
- HIV/AIDS
Studies from University of California Reveal New Findings on HIV/AIDS - HIV/AIDS
Data from Federal University Advance Knowledge in HIV/AIDS - HIV/AIDS
Findings from Chinese Academy of Sciences Broaden Understanding of HIV/AIDS - HIV/AIDS
Findings from DePaul University Broaden Understanding of HIV/AIDS - HIV/AIDS
New Findings in HIV/AIDS Described by A. Amendola and Co-Researchers - HIV/AIDS
New HIV/AIDS Study Findings Have Been Published by Scientists at University of Pennsylvania - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
